Influenza A (H1N1). Experience in the United States;Gripe A (H1N1). Experiencia de Estados Unidos

Archivos de Bronconeumologia

Volumn 46, Issue SUPPL. 2, 2010, Pages 13-18

  Restrepo, Marcos I ^a,b   Mazo, Marcela ^a,b   Anzueto, Antonio ^b  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antiviral agents; Influenza; Pneumonia

Indexed keywords

OSELTAMIVIR; PERAMIVIR; ZANAMIVIR;

AGE DISTRIBUTION; ARTICLE; DISEASE ACTIVITY; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; NONHUMAN; NORTH AMERICA; OBESITY; PANDEMIC INFLUENZA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX RATIO; UNITED STATES; VIRUS TRANSMISSION;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; UNITED STATES;

EID: 77950348150     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(10)70015-6     Document Type: Article

References (50)

1. Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:400-2.
2. Update: influenza activity-United States, April-August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1009-12.
3. Centers for Disease Control and Prevention Gripe H1N1 de 2009 - Actualización de la situación en EE.UU. 2009. Disponible en: http://espanol.cdc.gov/enes/h1n1flu/updates/us/.
4. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615.
5. Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:536-41.
6. Pérez-Padilla R., De la Rosa-Zamboni D., Ponce de León S., Hernández M., Quinones-Falconi F., Bautista E., et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361:680-689.
7. Swine-origin influenza A (H1N1) virus infections in a school - New York City, April. 2009. MMWR Morb Mortal Wkly Rep. 2009;58:470-2.
8. Centers for Disease Control and Prevention 2009 H1N1 Flu U.S. Situation Update. 2009. Disponible en: http://www.cdc.gov/h1n1flu/updates/us/111309.htm.
9. Human infection with pandemic A (H1N1) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009 - update. Wkly Epidemiol Rec. 2009;84:305-8.
10. Dodds L., McNeil S.A., Fell D.B., Allen V.M., Coombs A., Scott J., et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007, 176:463-468.
11. Jamieson D.J., Honein M.A., Rasmussen S.A., Williams J.L., Swerdlow D.L., Biggerstaff M.S., et al. H1N1. 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374:451-458.
12. Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May. 2009. MMWR Morb Mortal Wkly Rep. 2009;58:497-500.
13. Centers for Disease Control and Prevention Updated Interim recommendations for Obstetric Health Care Providers Related to Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season. 2009. Disponible en: http://www.cdc.gov/h1n1flu/pregnancy/antiviral_messages.htm.
14. Harris J. Influenza occurring in pregnant women: A statitical study of thirteen hundred and fifty cases. JAMA 1919, 72:978-980.
15. Centers for Disease Control and Prevention. Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel. 2009. Disponible en: http://www.cdc.gov/h1n1flu/guidelines_infection_control.htm.
16. Siegel J.D., Rhinehart E., Jackson M., Chiarello L. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control 2007, 35:S65-S164.
17. Daugherty E.L., Perl T.M., Needham D.M., Rubinson L., Bilderback A., Rand C.S. The use of personal protective equipment for control of influenza among critical care clinicians: A survey study. Crit Care Med 2009, 37:1210-1216.
18. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
19. Estimated county-level prevalence of diabetes and obesity -- United States, 2007. MMWR Morb Mortal Wkly Rep. 2009;58:1259-63.
20. Louie J.K., Acosta M., Winter K., Jean C., Gavali S., Schechter R., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902.
21. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep. 2009;58:749-52.
22. Akinnusi M.E., Pineda L.A., El Solh A.A. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 2008, 36:151-158.
23. Duarte A.G., Justino E., Bigler T., Grady J. Outcomes of morbidly obese patients requiring mechanical ventilation for acute respiratory failure. Crit Care Med 2007, 35:732-737.
24. Morris A.E., Stapleton R.D., Rubenfeld G.D., Hudson L.D., Caldwell E., Steinberg K.P. The association between body mass index and clinical outcomes in acute lung injury. Chest 2007, 131:342-348.
25. El-Solh A., Sikka P., Bozkanat E., Jaafar W., Davies J. Morbid obesity in the medical ICU. Chest 2001, 120:1989-1997.
26. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection - United States, April-August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:941-7.
27. Bhat N., Wright J.G., Broder K.R., Murray E.L., Greenberg M.E., Glover M.J., et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005, 353:2559-2567.
28. Finelli L., Fiore A., Dhara R., Brammer L., Shay D.K., Kamimoto L., et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008, 122:805-811.
29. Centers for Disease Control and Prevention U.S. Influenza-associated Pediatric Mortality 2009. Disponible en: http://www.cdc.gov/h1n1flu/updates/us/.
30. Chowell G., Bertozzi S.M., Colchero M.A., López-Gatell H., Alpuche-Aranda C., Hernández M., et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009, 361:674-679.
31. Kumar A., Zarychanski R., Pinto R., Cook D.J., Marshall J., Lacroix J., et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302:1872-1879.
32. Domínguez-Cherit G., Lapinsky S.E., Macias A.E., Pinto R., Espinosa-Pérez L., De la Torre A., et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302:1880-1887.
33. Booth C.M., Matukas L.M., Tomlinson G.A., Rachlis A.R., Rose D.B., Dwosh H.A., et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003, 289:2801-2809.
34. Davies A., Jones D., Bailey M., Beca J., Bellomo R., Blackwell N., et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009, 302:1888-1895.
35. Performance of rapid influenza diagnostic tests during two school outbreaks of 2009 pandemic influenza A (H1N1) virus infection - Connecticut, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1029-32.
36. Centers for Disease Control and Prevention Interim Recommendations for Clinical Use of Influenza Diagnostic Tests During the 2009-10 Influenza Season 2009. Disponible en: http://www.cdc.gov/h1n1flu/guidance/diagnostic_tests.htm.
37. Vasoo S., Stevens J., Singh K. Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1. Clin Infect Dis 2009, 49:1090-1093.
38. Update on influenza A (H1N1) 2009 monovalent vaccines. MMWR Morb Mortal Wkly Rep. 2009;58:1100-1.
39. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58:1-52.
40. Prevention CDC. H1N1 Clinicians Questions and Answers: Recommendations for the 2009 H1N1 Vaccine. 2009.
41. Centers for Disease Control and Prevention. 2009. H1N1 Influenza Vaccine Supply Status. 2009. Disponible en: http://www.cdc.gov/h1n1flu/vaccination/vaccinesupply.htm.
42. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, et al. Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine - Preliminary Report. N Engl J Med. 2009. Epublished ahead.
43. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine - Preliminary Report. N Engl J Med. 2009. Epublished ahead.
44. Hampton T. H1N1 vaccine urged for health workers, but some resist getting on board. JAMA 2009, 302:1848-1849.
45. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:433-5.
46. Prevention CDC. Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010. Season, 2009.
47. Smith J.R., Ariano R.E., Toovey S. The use of antiviral agents for the management of severe influenza. Crit Care Med 2010, 38:S1-S9.
48. Dharan N.J., Gubareva L.V., Meyer J.J., Okomo-Adhiambo M., McClinton R.C., Marshall S.A., et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009, 301:1034-1041.
49. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:969-72.
50. Birnkrant D., Cox E. The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 2009, 361:2204-2207.